1. Home
  2. NLSP vs AMST Comparison

NLSP vs AMST Comparison

Compare NLSP & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AMST
  • Stock Information
  • Founded
  • NLSP 2015
  • AMST 2017
  • Country
  • NLSP Switzerland
  • AMST United States
  • Employees
  • NLSP N/A
  • AMST N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • AMST Technology
  • Exchange
  • NLSP Nasdaq
  • AMST Nasdaq
  • Market Cap
  • NLSP 243.8M
  • AMST 6.6M
  • IPO Year
  • NLSP 2021
  • AMST 2020
  • Fundamental
  • Price
  • NLSP $4.96
  • AMST $2.69
  • Analyst Decision
  • NLSP
  • AMST
  • Analyst Count
  • NLSP 0
  • AMST 0
  • Target Price
  • NLSP N/A
  • AMST N/A
  • AVG Volume (30 Days)
  • NLSP 34.6K
  • AMST 15.9K
  • Earning Date
  • NLSP 11-01-2024
  • AMST 11-11-2024
  • Dividend Yield
  • NLSP N/A
  • AMST N/A
  • EPS Growth
  • NLSP N/A
  • AMST N/A
  • EPS
  • NLSP N/A
  • AMST N/A
  • Revenue
  • NLSP N/A
  • AMST $166,881.00
  • Revenue This Year
  • NLSP N/A
  • AMST N/A
  • Revenue Next Year
  • NLSP N/A
  • AMST N/A
  • P/E Ratio
  • NLSP N/A
  • AMST N/A
  • Revenue Growth
  • NLSP N/A
  • AMST N/A
  • 52 Week Low
  • NLSP $4.08
  • AMST $1.72
  • 52 Week High
  • NLSP $29.68
  • AMST $4.34
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 46.37
  • AMST 61.55
  • Support Level
  • NLSP $4.52
  • AMST $2.49
  • Resistance Level
  • NLSP $5.64
  • AMST $2.64
  • Average True Range (ATR)
  • NLSP 0.48
  • AMST 0.13
  • MACD
  • NLSP 0.07
  • AMST 0.03
  • Stochastic Oscillator
  • NLSP 55.44
  • AMST 93.10

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology-driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are businesses, universities and colleges, and K-12 schools.

Share on Social Networks: